Comparative binding of antitumor indazolium [trans-tetrachlorobis(1H- indazole)ruthenate(III)] to serum transport proteins assayed by capillary zone electrophoresis

Analytical Biochemistry

Volumn 341, Issue 2, 2005, Pages 326-333

  Timerbaev, Andrei R ^a,b   Rudnev, Alexander V ^b   Semenova, Olga ^a   Hartinger, Christian G ^a   Keppler, Bernhard K ^a  

^a UNIVERSITY OF VIENNA   (Austria)

^b VERNADSKY INSTITUTE OF GEOCHEMISTRY AND ANALYTICAL CHEMISTRY   (Russian Federation)

Author keywords

Binding constants; Capillary electrophoresis; Human serum proteins; Protein binding kinetics; Ruthenium complexes

Indexed keywords

BIOCHEMISTRY; CAPILLARY ELECTROPHORESIS; COORDINATION REACTIONS; PROTEINS; RUTHENIUM COMPOUNDS; TUMORS;

ANTI-PROLIFERATIVE ACTIVITIES; BINDING CONSTANT; CAPILLARY ZONE ELECTROPHORESIS; CONCENTRATION-DEPENDENT; HUMAN SERUM PROTEINS; PHYSIOLOGICAL CONDITION; PROTEIN BINDING; RUTHENIUM COMPLEXES;

RATE CONSTANTS;

ALBUMIN; ANTINEOPLASTIC AGENT; CARRIER PROTEIN; INDAZOLIUM; RUTHENIUM COMPLEX; TRANSFERRIN; UNCLASSIFIED DRUG;

ANALYTIC METHOD; ARTICLE; BINDING AFFINITY; BINDING KINETICS; CAPILLARY ZONE ELECTROPHORESIS; CONCENTRATION RESPONSE; DRUG PROTEIN BINDING; MATHEMATICAL ANALYSIS; PRIORITY JOURNAL; STOICHIOMETRY; TIME;

EID: 19544367738     PISSN: 00032697     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ab.2005.03.020     Document Type: Article

References (31)

1. Z. Guo, and P.J. Sadler Medicinal inorganic chemistry Adv. Inorg. Chem. 49 2000 183 306
2. G. Sava, and A. Bergamo Ruthenium-based compounds and tumor growth control Int. J. Oncol. 17 2000 353 365
3. C.S. Allardyce, and P.J. Dyson Ruthenium in medicine: current clinical uses and future prospects Platinum Metals Rev. 45 2001 62 69
4. M.J. Clarke Ruthenium metallopharmaceuticals Coord. Chem. Rev. 236 2003 209 233
5. M. Galanski, V.B. Arion, M.A. Jakupec, and B.K. Keppler Recent developments in the field of tumor-inhibiting metal complexes Curr. Pharm. Des. 9 2003 2078 2089
6. E.D. Kreuser, B.K. Keppler, W.E. Bardel, A. Priest, and E. Thiel Synergistic antitumor interactions between newly synthesized ruthenium complexes and cytokines in human colon carcinoma cell lines Semin. Oncol. 19 1992 73 81
7. F. Kratz, B.K. Keppler, M. Hartmann, L. Messori, and M.R. Berger Comparison of the antiproliferative activity of two antitumor ruthenium(III) complexes with their apotransferrin and transferrin-bound forms in a human colon cancer cell line Metal-Based Drugs 3 1996 15 24
8. J. Malina, O. Novakova, B.K. Keppler, E. Alessio, and V. Brabec Biophysical analysis of natural, double-helical DNA modified by anticancer heterocyclic complexes of ruthenium(III) in cell-free media J. Biol. Inorg. Chem. 6 2001 435 445
9. B.K. Keppler, G. Eisenbrand, M.A. Jakupec, in: H.H. Fiebig, A.M. Burger (Eds.), Relevance of Tumor Models for Anticancer Drug Development, Vol. 54 of Contributions to Oncology, W. Queisser, W. Scheithauer (Eds.), Karger, Basel, 1999, pp. 361-367
10. F. Kratz, M. Hartmann, B.K. Keppler, and L. Messori The binding properties of two antitumor ruthenium(III) complexes to apotransferrin J. Biol. Chem. 269 1994 2581 2588
11. B.P. Espósito, and R. Najjar Interactions of antitumoral platinum-group metallodrugs with albumin Coord. Chem. Rev. 232 2002 137 149
12. F. Kratz B.K. Keppler Metal Complexes in Cancer Chemotherapy 1993 VCH Weinheim 391 429
13. F. Kratz, B.K. Keppler, L. Messori, C. Smith, and E.N. Baker Protein-binding properties of two antitumor Ru(III) complexes to human apotransferrin and apolactoferrin Metal-Based Drugs 1 1994 169 173
14. 2] and serum proteins J. Inorg. Biochem. 98 2004 1135 1142
15. L. Messori, F. Gonzales Vilchez, R. Vilaplana, F. Piccioli, E. Alessio, and B. Keppler Binding of antitumor ruthenium(III) complexes to plasma proteins Metal-Based Drugs 7 2000 335 342
16. M. Pongratz, P. Schluga, M.A. Jakupec, V.B. Arion, C.G. Hartinger, G. Allmaier, and B.K. Keppler Transferrin binding and transferrin-mediated cellular uptake of the ruthenium coordination compound KP1019, studied by means of AAS, ESI-MS and CD spectroscopy J. Anal. At. Spectrom. 19 2004 46 51
17. L. Trynda-Lemiesz, A. Karaczyn, B.K. Keppler, and H. Kozłowski Studies on the interactions between human serum albumin and trans- indazolium(bisindazole)tetrachlororuthenate(III) J. Inorg. Biochem. 78 2000 341 346
18. A.R. Timerbaev, A. Küng, and B.K. Keppler Capillary electrophoresis of platinum-group elements. Analytical, speciation and biochemical studies J. Chromatogr. A 945 2002 25 44
19. C.G. Hartinger, A.R. Timerbaev, and B.K. Keppler Capillary electrophoresis in anti-cancer metallodrug research: advances and future challenges Electrophoresis 24 2003 2023 2037
20. - investigated by means of HPCE and HPLC-MS J. Biol. Inorg. Chem. 6 2001 292 299
21. A. Küng, T. Pieper, and B.K. Keppler Investigations into the interaction between tumor-inhibiting ruthenium(III) complexes and nucleotides by capillary electrophoresis J. Chromatogr. B 759 2001 81 89
22. A.R. Timerbaev, S.S. Aleksenko, K. Polec-Pawlak, R. Ruzik, O. Semenova, C.G. Hartinger, S. Oszwaldowski, M. Galanski, M. Jarosz, and B.K. Keppler Platinum metallodrug-protein binding studies by capillary electrophoresis- inductively coupled plasma-mass spectrometry: characterization of interactions between Pt(II) complexes and human serum albumin Electrophoresis 25 2004 1988 1995
23. A.V. Rudnev, S.S. Aleksenko, O. Semenova, C.G. Hartinger, A.R. Timerbaev, and B.K. Keppler Determination of binding constants and stoichiometries for platinum anticancer drugs and serum transport proteins by capillary electrophoresis using the Hummel-Dreyer method J. Sep. Sci. 28 2005 121 127
24. K.G. Lipponer, E. Vogel, and B.K. Keppler Synthesis, characterization and solution chemistry of indazolium trans-tetrachlorobis(indazole)ruthenate(III), a new anticancer ruthenium complex. IR, UV, NMR, HPLC investigations and antitumor activity. Crystal structures of 1-methylindazolium trans-tetrachlorobis-(1-methylindazole)ruthenate(III) and its hydrolysis product trans-monoaquatrichlorobis(1-methylindazole)ruthenate(III) Metal-Based Drugs 3 1996 243 260
25. T. Pieper, W. Peti, and B.K. Keppler Solvolysis of the tumor-inhibiting Ru(III)-complex trans-tetrachlorobis(indazole)ruthenate(III) Metal-Based Drugs 7 2000 225 232
26. A.G. Sykes Kinetics of Inorganic Reactions 1966 Pergamon Press London
27. F. Kratz, N. Mulinacci, L. Messori, I. Bertini, and B.K. Keppler J. Anastassopoulou Ph. Collery J.C. Etienne Th Theophanides Metal Ions in Biology and Medicine vol. 2 1992 John Libbey Eurotext Paris 69 74
28. J. Szpunar, A. Makarov, T. Pieper, B.K. Keppler, and R. Łobiński Investigation of metallodrug-protein interactions by size-exclusion chromatography coupled with inductively coupled plasma mass spectrometry (ICP-MS) Anal. Chim. Acta 387 1999 135 144
29. Y. Tanaka, and S. Terabe Estimation of binding constants by capillary electrophoresis J. Chromatogr. B 768 2002 81 92
30. X. He, Y. Ding, D. Li, and B. Lin Recent advances in the study of biomolecular interactions by capillary electrophoresis Electrophoresis 25 2004 697 711
31. M.H.A. Busch, L.B. Carels, H.F.M. Boelens, J.C. Kraak, and H. Poppe Comparison of five methods for the study of drug-protein binding in affinity capillary electrophoresis J. Chromatogr. A 777 1997 311 328